Crossmark

Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's Continuum

Crossref DOI link: https://doi.org/10.14283/jpad.2023.83

Published Print: 2023-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Feizpour, A.

Doré, V.

Doecke, J.D.

Saad, Z.S.

Triana-Baltzer, G.

Slemmon, R.

Maruff, P.

Krishnadas, N.

Bourgeat, P.

Huang, K.

Fowler, C.

Rainey-Smith, S.R.

Bush, A.I.

Ward, L.

Robertson, J.

Martins, R.N.

Masters, C.L.

Villemagne, V.L.

Fripp, J.

Kolb, H.C.

Rowe, Christopher C.
License Information

Text and Data Mining valid from 2023-11-01

Text and Data Mining valid from 2023-11-01

Version of Record valid from 2023-07-05
More Information

This article is maintained by: Elsevier

Article Title: Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's Continuum

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2023.83

Content Type: article

Copyright: Copyright © 2023 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS